Fortress Biotech, Inc. (FBIOP) EPS (Basic) (2010 - 2026)
Fortress Biotech (FBIOP) posted quarterly EPS (Basic) of -$0.22 for Q4 2025, up 52.17% year-over-year from -$0.15 in Q4 2024, and down 264.68% quarter-over-quarter from $0.13 in Q3 2025.
Fortress Biotech, Inc. (FBIOP) EPS (Basic) (2010 - 2026) Analysis & Trends
Fortress Biotech's EPS (Basic) history runs 16 years deep, the most recent figure standing at -$0.22 for Q4 2025.
- In Q4 2025, EPS (Basic) rose 52.17% year-over-year to -$0.22; the TTM figure through Dec 2025 stood at -$0.07 (up 97.49% YoY), while the FY2025 annual figure was -$0.07, up 97.49% from the prior year.
- EPS (Basic) for Q4 2025 stood at -$0.22, down from $0.13 in the prior quarter.
- The five-year high for EPS (Basic) was $0.5 in Q2 2025, with the low at -$10.99 in Q4 2021.
- The 5-year median for EPS (Basic) is -$2.43 (2023), against an average of -$3.47.
- The sharpest annual moves came in 2021 and 2025: EPS (Basic) plunged 101.37% in 2021, then surged 168.23% in 2025.
- Fortress Biotech's EPS (Basic) stood at -$10.99 in 2021, then surged by 55.53% to -$4.89 in 2022, then soared by 71.52% to -$1.39 in 2023, then soared by 66.63% to -$0.46 in 2024, then soared by 52.17% to -$0.22 in 2025.
- Business Quant data shows FBIOP's EPS (Basic) at -$0.22 in Q4 2025, $0.13 in Q3 2025, and $0.5 in Q2 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.08 |
| Dec 31, 2025 | -0.22 |
| Sep 30, 2025 | 0.13 |
| Jun 30, 2025 | 0.50 |
| Mar 31, 2025 | -0.48 |
| Dec 31, 2024 | -0.46 |
| Sep 30, 2024 | -0.76 |
| Jun 30, 2024 | -0.73 |
| Mar 31, 2024 | -1.04 |
| Dec 31, 2023 | -1.39 |
| Sep 30, 2023 | -0.94 |
| Jun 30, 2023 | -3.65 |
| Mar 31, 2023 | -3.47 |
| Dec 31, 2022 | -4.89 |
| Sep 30, 2022 | -4.11 |
| Jun 30, 2022 | -3.95 |
| Mar 31, 2022 | -8.60 |
| Dec 31, 2021 | -10.99 |
| Sep 30, 2021 | -10.00 |
| Jun 30, 2021 | -8.42 |